ArticleTrials2019

Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.

Sara Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.